In 11 normal volunteers and six patients with Parkinson's disease, we compared six different analyses of dopaminergic fu nction with L-3, 4-dihydroxy-6-[18F]fluorophenylalanine (FDOPA) and positron emission tomography (PET). The caudate nucleus, putamen, and several reference regions were identified in PET images, using magnetic resonance imaging (MRI). The six analy ses included two direct determinations of DOPA decar boxylase activity (kr;, kj), the slope-intercept plot based on plasma concentration (K), two slope-intercept plots based on tissue content (k�, k�), and the striato-occipital ratio [R(n]. For all analyses, the difference between two groups of subjects (normal volunteers and patients with Parkinson's disease) was larger in the putamen than in the caudate. For the caudate nucleus, the DOPA decarbox ylase activity (kr;, kj), tissue slope-intercept plots (k;, The tracer L-3,4-dihydroxy-6-esF]fluorophenyl alanine (FDOPA) has been used widely to evaluate striatal dopaminergic functions in humans by posi tron emission tomography (PET). The enzyme aro matic amino acid decarboxylase (AAAD), or L-DOPA decarboxylase, is responsible for the re-
Summary:
In 11 normal volunteers and six patients with Parkinson's disease, we compared six different analyses of dopaminergic fu nction with L-3, 4-dihydroxy-6-[18F]fluorophenylalanine (FDOPA) and positron emission tomography (PET). The caudate nucleus, putamen, and several reference regions were identified in PET images, using magnetic resonance imaging (MRI). The six analy ses included two direct determinations of DOPA decar boxylase activity (kr;, kj), the slope-intercept plot based on plasma concentration (K), two slope-intercept plots based on tissue content (k�, k�), and the striato-occipital ratio [R(n] . For all analyses, the difference between two groups of subjects (normal volunteers and patients with Parkinson's disease) was larger in the putamen than in the caudate. For the caudate nucleus, the DOPA decarbox ylase activity (kr;, kj), tissue slope-intercept plots (k;,
The tracer L-3,4-dihydroxy-6-esF]fluorophenyl alanine (FDOPA) has been used widely to evaluate striatal dopaminergic functions in humans by posi tron emission tomography (PET). The enzyme aro matic amino acid decarboxylase (AAAD), or L-DOPA decarboxylase, is responsible for the re-tention of FDOPA in the striatum, in analogy with the role of hexokinase in the retention of tracer [lsF] fluoro-deoxY-D-glucose (FDG) . However, un like the native substrate of hexokinase, which orig inates in plasma, the native substrates of L-DOPA decarboxylase are generated in the tissue. Thus, un like the net clearance of FDG, the net clearance of FDOPA is not directly relevant to the rate of decar boxylation of aromatic amino acids. Conversely, determination of the enzyme activity by the FDOPA-PET method suffers from uncertainties as sociated with the determination of exchange be tween the compartments of a multicompartment model (Kuwabara et aI ., 1990) . The accumulation of FDOPA metabolites in plasma further complicates the analysis.
One solution to this problem is to constrain the transfer coefficients within physiological bounds (J!j, kj) (Gjedde et aI., 1991; Huang et aI ., 1991; Kuwabara et aI ., 1992a) . Others have simplified the compartmental model to yield a net clearance (K) (Martin et aI., 1989) , assuming negligible decarbox ylation in a reference region such as the occipital cortex, or a modified decarboxylation coefficient (�, kD (Brooks et aI ., 1990a,b; Hartvig et aI ., 1991) .
Even simpler is the calculation of the ratio between the sum of FDOPA and its metabolites in the stria tum and the same sum in a reference region (Martin et aI., 1986; Leenders et aI., 1986a,b) .
The present study compares, in normal volun teers and patients, the power of the six different analyses of FDOPA uptake to discriminate Parkin son's disease from normal physiology on the basis of changes in the caudate nucleus and putamen (Brooks et aI., 1990a,b) . For the practical users of PET, the primary aim often is to differentiate the abnormal from the normal in a manner proportional to the magnitude of the abnormality. At the same time, it is important for the PET procedures to be simple and less demanding on patients and users. The above six analytical methods vary, in terms of the theoretical and practical compromises and sim plification, from the most complete but most de manding analyses (k�, kV to the simplest and least demanding target-reference region radioactivity ra tio. Therefore, the purpose of the present study is to test the practicality of the simplified versions of the FDOPA-PET analysis, using the k� analysis as the "gold standard ."
MATERIALS AND METHODS

Patient selection
Data were acquired for 11 normal volunteers and six patients with Parkinson's disease. Mean ages of the two groups were 44 ± 16 and 58 ± 9 years (mean ± SD), respectively. All patients suffered locomotive disability of 3 or 4 on the Hoehn and Yahr scale (Hoehn and Yahr, 1967) with "on-off' phenomenon (Claveria et aI., 1973) . We found no significant laterality of the symptoms.
Positron emission tomography procedures
All subjects were fasted overnight and received 100 mg Carbidopa 2 h before the PET study. The antiparkinso nian medication of patients was withdrawn at least 12 h before the study.
After signing an informed consent form, subjects re clined on a couch. The head was lightly immobilized in a custom-made head-holder with rapidly setting foam. Thin catheters were introduced into a radial artery for blood sampling, and into a brachial vein for injection of tracer. The subjects were then positioned in the Scanditronix PC-2048 15B PET scanner with fifteen simultaneous planes of 6.5-mm interval and an 11-mm effective recon struction full-width at half-maximum (FWHM) (Evans et aI., 1991a) . Tissue attenuation was determined with a 51 1 keY 'Y source (6SGa). During the 90 min fo llowing intra venous injection of 5 mCi FDOP A, 27 frames were ex posed, including six 30-s, seven I-min, five 2-min, four 5-min, and five lO-min frames. Arterial blood was sam-J Cereb Blood Flow Metab, Vol. 13, No.1, 1993 pled every 10 s in the beginning and with increasing in tervals toward the end of study. After centrifugation, plasma radioactivity was determined and 10 samples were fractionated by high-performance liquid chromatography at 2. 5, 5, 10, 15, 20, 25, 30, 35, 45 , and 60 min after injection (Boyes et aI., 1986; Cumming et aI., unpublished data, 1992) . In a few cases 75-and 90-min samples also were analyzed by HPLC. Separately, 64 axial MR images of 2-mm thickness were obtained.
Anatomical identification of the cerebral structures was aided by MRI-PET correlation (Evans et aI., 1991b) . In each subject, the MRI volume was "resliced" along planes parallel to the PET planes after optimal transfor mation by minimization of the root-mean-square distance between all paired equivalent points identified on MR and transmission images. We identified and outlined the fol lowing cerebral structures as regions-of-intere st (ROI) templates on two adjacent "re sliced" MRI planes; head of the caudate nucleus; putamen; inferior, middle, and superior frontal gyri; and lateral and medial occipital cor tices. The time-courses of radioactivity in these struc tures were obtained by applying the stored ROI templates to successive PET frames. For data analysis, we used the weighted averages of the two planes for each side (cau date and putamen), or for both sides and subdivisions (frontal and occipital cortices). The average areas of the caudate, putaminal, frontal, and occipital ROIs were 1.2, 3.2, 8.3 and 6. 1 cm2 per plane.
Data analysis
Several methods have yielded parameters of interest to dopaminergic fu nction. The fo llowing are six different analyses, proposed for the estimation of these parame ters. In the analysis, the left and right caudate and puta men were treated as distinct structures because the L-DOPA kinetics and their pathological impairment could differ from side to side within a single subject (Leenders et al., 1990) . Dopa decarboxylase activity (kf, kj). The kf method is designed to provide a complete interpretation of FDOPA uptake into brain accounting for all major radioactivity sources in brain, compartmentalized by physiological (blood-brain barrier) or chemical (enzymes) interfaces (Gjedde et aI., 1991; Kuwabara et aI., 1992a) . The model assumes six states of lsF activity in brain: fluoro-3-0-methylphenylalanine (OMFD) in the vascular and tissue compartments (C�(t), C�(t), M�\t), and MM(t», fluorodopamine (FDA) and its nondiffusible metabolites (M�(t)), and diffusible FDA metabolites (M:;(t)), consisting of L-3,4-6-[lSF]fluoro dihydroxyphenylacetic acid (FDOPAC) and eSF]6-fluorohomovanillic acid (FHVA). Changes of radioactiv ity contents in the compartments are described by the following differential equations:
and, (1)), and total radioactivity measured in a region by PET (M (1)). In the analysis, we used the biological constraints of a common value of the partition volume ( Ve = Kl/k2)
for the frontal lobe and striatum (Kuwabara et aI ., 1992a) , and a fixed KI ratio between FDOPA and OMFD (2 .3; Reith et aI., 1990 and,
where k! is the clearance rate constant for FDA and its metabolites from the tissue to plasma. Although the phys iological meaning of the corresponding transfer coeffi cients of the kfj and kj analyses are identical, we differ entiate them by the superscripts to clarify their attribu tions. We estimated Kj, ki, kj, and Vo with a partition volume of OMFD of unity, and a KI ratio of 1.7, as re commended by the authors. We also fixed k! to the re ported mean value (0.0043 min -I ) .
Plasma slope-intercept plot (K). The slope-intercept plot was described by Gjedde (1981 Gjedde ( , 1982 and Patlak et ai. (1983) . Martin et ai. (1989) and Martin (1990) used this graphical analysis to determine FDOPA uptake, assuming that the radioactivity in a cortical region of reference con sists only of FDOPA and OMFD, and that identical quan tities of these two compounds are present in the striatum. The plot predicts that the volume of distribution is related the normalized plasma integral,
where (M -Mr)/C:? (1) is the so-called "specific" striatal radioactivity normalized to the plasma FDOP A activity at the appropriate time, fl Ca(t)dtICa (1) Tissue Slope-Intercept Plot (k�, k�). This variation of the slope-intercept plot was described by Patlak and Blasberg (1985) as an extension of the plasma slope intercept plot. The rate constant of trapping is calculated from the radioactivity in a reference region rather than in plasma (k�; Brooks et aI., 1990a,b, k�; Hartvig et aI., 1991) . In a compartment model (Hartvig et aI., 1991) , the fo llowing differential equations describe the accumula tion of tracer and tracer metabolites in a region of metab olism and in a reference region of no metabolism,
where Me(t) is the intact radio tracer content, Mm(t) the "specific" metabolite content, M/t) the activity content of a reference region, Ca(t) the plasma concentration of radiotracer, KI and k2 the transfer coefficients for influx and efflux in the striatum and reference region (super script '), and k3 the first order rate constant for metabo lism of the tracer. Assuming that Me(t) is proportional to M/t) at all times (ratio = Ro, hence f� Me(t)dt = Ro f l Mr(t)dt), Me(t) and f� Me(t)dt are replaced with RoMr(t) and Ro f� Mr(t)dt in M(t) = Me + Mm(t) and the integral of Eq. (9);
Thus, the plot of M(1)IMr(1) versus f� Mr(t)dtIMr (1) is, by definition, linear with ordinate intercept of Ro. The slope k3RO (denoted by kD is proportional to k3 and the slope-intercept ratio k3R01Ro (denoted by �) is equal to k3• Different users have computed the slope starting with values of the ab scissa of 5 or 30 min and ending at 90 min of real time. We compared the effe ct of using 5 and 30 min as starting points. Striata-occipital radioactivity ratio (R( T)). This method calculates the simple ratio of activity in a region of intere st (e .g. caudate and putamen) to activity in a reference region, normalized to ROI size (Martin et aI., 1986; Leenders et aI., 1986a,b) . It is usually calculated from the PET fr ame obtained 80-90 min after injection of FDOPA. By definition,
Statistical methods. The mean value and standard de viation of each parameter were calculated for all six meth ods, and results were expressed as mean ± SD. Student's t tests were used for comparisons. The correlation be tween two parameters was evaluated by linear regression analysis. A probability value of less than 0.05 was con sidered significant for each analysis. The p values were corrected for mUltiple comparisons according to the Bon fe rroni procedure (McClave and Dietrich, 1988 ). Figure 1 shows the plasma slope-intercept plot (Fig. lA) , and the tissue slope-intercept plot (Fig.  IB) , for the left putamen of a repre sentative normal volunteer and a patient with Parkinson's disease .
RESULTS
The plasma slope-intercept plot assumed strict linearity after a circulation time of 30 minutes. Cor relation coefficients (r) exceeded 0.97 (r 2 > 0.95) in 65 of 68 striatal ROls of normal volunteers and pa tients with Parkinson's disease.
The tissue slope-intercept plot was approxi mately linear after a circulation time of 30 min. However, the plot almost never was strictly linear, and the slope tended to decrease at later times, es pecially in normal volunteers . Correlation coeffi- intercept analysis failed to yield this discrimination.
Of a total of 34 caudate nuclei examined, the kP values of five normal subjects were lower than the highest kP value of one patient (5/22) . Conversely, the values of three patients were higher than the lowest kP value of a normal volunteer (3/12). The same comparisons for kt, K, k�, k3' and R yielded proportions of 13/22 and 5/ 12, 18/22 and 12/12, 6/22 and 2/12, 4/22 and 7/ 12, and 9/22 and 10/12, respec tively .
The putaminal kP, kt, kL k3' and R values of normal volunteers were significantly higher than those of patients (p < 0.005), as was the value for K (p < 0.025) . The putaminal kt values of two normal subjects were lower than the highest kt value of a patient (2/22), while the putaminal kt values of six patients were higher than the lowest normal control (6/12) . The same comparisons for the plasma slope intercept plot (K) and R yielded proportions of 10/22 and 12/12, and 2/22 and 2/12, respectively. 
Right caudate nucleus 0. 14 0. 14 '0 * --, In the putamen, k�, k;, K , k;, k3, and R(T) of normal volunteers were all significantly higher than of patients with the least probability for K (p < 0.005, p < 0.025, respectively). 'p < 0.005, tp < 0.025, :j:p < 0.05. Correlations between k� and kf (Fig. 4A,B ), k� and � (Fig. 4E,F) , and k� and k� (Fig. 4G ,H) were sig nificant (p < 0. 00 1) in both caudate nucleus and putamen. The correlation between k� and R (Fig.   41 ,1) was significant in the putamen (p < 0.001) but less significant in the caudate nucleus (p < 0. 01).
The correlation between k� and K (Fig. 4C,D) was least significant in the putamen and not significant in the caudate nucleus. Figure 5A compares the net clearance calculated on the basis of the k� analysis (KD = KP�/[KPIVe + �)) and the K estimates of the plasma slope intercept plot. The K estimates systematically de viated from the KD estimates, with a significant lin ear correlation for control subjects (r = 0.97, p < 0.000 1) and for patients with Parkinson's disease (r = 0. 87, p < 0. 00 1). Figure 5B compares correlated for controls (r = 0. 90, p < 0.001) and for patients with Parkinson's disease (r = 0.92, p < 0. 00 1). The plots deviated most from the line of identity when the KD estimates were small. Figure  5C compares the Ve estimates of the frontal cortex determined by the k� analysis and the striatal K of the plasma slope-intercept plot. For the same value of Ve, the K estimates of patients appeared lower than those of controls. The Ve-K ratios of patients (0. 02 1 ± 0. 006 , n = 24) were significantly lower than those of control subjects (0. 032 ± 0.04 , n = 44) (p < 0. 0001) (see Eq. 19 in Discussion). Figure 5D compares and R estimates are listed for normal controls and patients with Parkinson's disease in Table 1 . (Firnau et al ., 1973 ; Garnett et al., 1983; Cumming et al., 1988) . FDOPA , the metabolite OMFD, and a num ber of endogenous amino acids are transported from the circulation to brain tissue by an endothelial membrane transporter of large neutral amino acids (Oldendorf and Szabo, 1976) . FDOPA uptake oc curs in all regions of the brain, but retention occurs mainly in the caudate nucleus and putamen (Garnett et aI., 1984) . The enzyme DOPA decarboxylase cat alyzes the formation of dopamine (DA) from DOPA (Lovenberg et aI ., 1962) . The decarboxylated prod uct fluorodopamine (FDA) is metabolized to fluo rodihydroxyphenylacetic acid (FDOPAC) and fluo rohomovanilic acid (FHVA) (Cumming et aI ., 1987; Firnau et aI ., 1987; Melega et aI ., 1991) .
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The striato-occipital radioactivity radio R(T) is a function of dopaminergic action because FDOPA derived radioactivity is retained mainly in the stri atum , while OMFD is present in all brain regions with little regional variation (Melega et aI ., 1991) . Leenders et aI . (1986b) ato-occipital ratio is an index of combined effects of the tissue's tracer transport, decarboxylation, and ability to retain FDA metabolites. The present re sults confirm the increasing striato-occipital ratio (Fig. 2) and suggest that R(T) should be calculated late in the study because of the greater discrimina tion between normal volunteers and Parkinson's disease at late times. This discrimination was less pronounced in the caudate nucleus than in the puta men.
The striato-occipital ratio is more precisely ex pressed as
MD(T) + MM(T) R(T) = M�(T) + M�(T)
( 13) where the superscript D refers to FDOPA and its metabolites after decarboxylation, and the super- script M to OMFD. Laihinen et al. (1992) chose cerebellum as the reference region and demon strated that the striat<reerebellar ratio increased by 20% following pretreatment with a peripherally ac tive catechol-O-methytransferase (COMT) inhibitor OR-462. The findings indicate that the major source of brain OMFD is from plasma and that the OMFD in brain influences the value of the ratio. In re sponse, we examined the relationships between the plasma OMFD-FDOPA ratio and the striato occipital ratio. We did not find any significant cor relation because of little variation of the plasma OMFD-FDOPA ratio across the subjects (data not shown). Furthermore , the presence of transporter competitors in plasma reduced the accumulation of FDOPA and its metabolites in brain but did not af fect the ratio (Leenders et al., 1986b) . We conclude that the striato-occipital ratio is a good index of FDOPA accumulation, especially for those patients who cannot tolerate immobilization. Users must in dicate the duration of the PET record included to calculate the ratio. The tissue slope-intercept plot utilizes the time dependent change of the striato-occipital ratio. This method has the advantage that it does not require blood sampling. The problem is to define when the linearity of the plot is accomplished. Brooks et al. (1990a,b) , who used FDOPA, found the plot to be linear between 30 and 90 min of real time. Hartvig et al. (1991) , who used L-[!3_ 11 C]DOPA, found the plot to be linear after 5 min of "integral time." In this study, we found the plot more linear between 30 and 90 min (the 30-90-min analysis) than between 5 and 90 min (the 5-90-min analysis) because the slope declined during the early phase of the study and reached an asymptote around 30 min (Fig. IB) , possibly due to the influence of OMFD. In Eq. (13), the ratio declines as a function of time because the FCDOPA increased by 60% fo llowing pretreatment with a both centrally and peripherally active COMT inhibitor [R040-7592], while those of CDOPA re mained unaffected by the pretreatment. They attrib uted the findings to the difference between the mag nitude of O-methylation in plasma; peripheral O-methylation of FCDOPA was rapid, and greater than that of CDOPA. For the central O-methylation of FDOPA , we concluded that it does not affect the kP estimates (Kuwabara et al. , 1992a) . Estimates fo llowing peripheral and central COMT inhibition were comparable to the 20% increase of the striato occipital ratio following peripheral inhibition (Laihi nen et al. , 1992) .
We recommend the 5-90-min analysis for both the k� and k� methods, because the 5-90-min anal ysis is likely to be less affected by influence from plasma OMFD. Individual estimates of the 5-90-and 30-90-min analyses were well-correlated, and the coefficients of variation (COYs) were smaller for the 5-90-min analysis than for the 30-90-min analysis.
In theory , the slope-intercept plots require that the test substance enters at least one compartment irreversibly. In the FDOPA studies, the irreversible compartment is formed by the decarboxylation of FDOPA to FDA. The retention of FDOPA-derived radioactivity in the striatum is effectively irrevers ible during the first hour after injection and there-fore reflects FDOPA decarboxylation (Chiueh et aI. , 1986; Firnau et aI. , 1987; Cumming et aI. , 1988) . Fortunately, for the FDOPA studies, there are also regions which do not have an irreversible compart ment. For this reason, the plasma slope-intercept plot directly assesses the metabolite compartment (M�(1)) by subtracting Mr(1) from the total radio activity (Eq. 7) , thus effectively eliminating the in fluence from OMFD (Martin et aI. , 1989 (Martin et aI. , , 1990 . In this sense, the plasma slope-intercept plot of the FDOPA studies is configured differently from that of the original plot (Gjedde, 1981 (Gjedde, , 1982 Patlak et aI. , 1983) (Fig. lA) .
In fact, the plasma slope-intercept plot yielded the K estimates practically proportional to those of the kf method (Fig. SA) . The systematic deviation is explained by the fact that the k� method took into account the loss of FDA metabolites from the brain. Nevertheless, in some cases in the present study , the value of K appeared to be an insensitive index of striatal fu nction, as indicated by the low correlation coefficient between k� and K. In contrast, the k� and � estimates had the highest correlation with the k� estimates.
What is the reason for the discrepancy between the plasma and tissue slope-intercept plots' ability to discriminate the FDOPA accumulation in physi ological and pathological conditions? A possible ex planation invokes the transport across the blood brain barrier. Both FDOPA and its major metabo lite in plasma, OMFD, are transported from the circulation to brain tissue by the transporter of large neutral amino acids (Wade and Katzman , 1975; Oldendorf and Szabo, 1976) . The transporter is nearly saturated and competitors in plasma inhibit the transport of both labeled compounds (Leenders et a!. , 1986b; Gjedde and Bodsch, 1987; Reith et a!. , 1987) . Assuming that the facilitated transporter is symmetrical into and out of the brain, the partition volume (Ve) is a function of the sum of all compet itors relative to their half-saturation concentrations (Gjedde, 1982) . Therefore , both unidirectional clearance and partition volume decline when the plasma competitors are elevated. The net clearance of FDOPA is redefined in terms of KP, k�, and Ve as follows:
The equation predicts that the net clearance of FDOPA is inversely correlated to the sum of plasma competitors when the L-DOPA decarboxylase ac tivity (k�) is constant. Leenders et ai. (l986a) FDOPA by changing the plasma amino acid concen trations.
Let us examine the tissue slope-intercept plot in more detail. When Eqs. (8) and (10) (Gjedde, 1982; Patlak and Blasberg , 1985) . Thus ,
Because of the deviation of the Me(1)IM/1) ratio fr om Ro at an early time after injection, IT; Me(t)dt does not necessarily approach Ro IT; M/t)dt (Patlak and Blasberg , 1985) . After eliminating the IT; Ca(t)dt term from the integrals of Eqs. (8) and (10), and rearranging, we obtain
In the derivation of Eq. (1 1), Me(1) and Mm(1) = k3 I 6 Me(t)dt are replaced by Mr(1) and IT; M/t)dt:
In the plot of M (1) The net clearance of the plasma slope-intercept plot correlated with the frontal cortex partition vol ume under physiological conditions (Fig. 5C , open circles). The overlap of the striatal K estimates of controls and patients with Parkinson's disease (filled circles) occurred when the large neutral amino acid transporter was saturated (i.e. , low Ve). We conclude that the net clearance of FDOPA can not be a useful indicator of FDOPA accumulation unless it is corrected for the saturation of the DOPA transporter.
Our frontal cortex Ve values had COY (28%), de spite the fasting of subjects overnight to eliminate the postprandial increase of amino acids (Fig. 5C ).
We estimated Ve in a reference region where kP is expected to be small and used this estimate as a fixed parameter for estimates of kP in the striatum (Gjedde et al. , 1991; Kuwabara et al. , 1992a) . Doudet et al. (1991) reported a COY of 10% for the striatal Ve of OMFD in four monkeys. Koeppe et al. (1990) The partition volume also underlies the essential difference between the kP and kj analyses. In kP and kj methods, the OMFD in the brain was sub tracted from the total radioactivity according to the estimates of the unidirectional clearance of FDOPA, the unidirectional clearance ratio between OMFD and FDOPA , and the partition volume. The partition volume was estimated in each subject in the kP method (0.64 ± 0. 18 ml cm-3 ) while the volume was set to unity in the kj method. Thus , on average, more radioactivity was subtracted as OMFD in the kj method than in the kP method. This explains the shift of the regression lines downward in the plot of the kP versus kj estimates (Fig. 4A,B ).
In addition, in the plot of the net clearance calcu lated on the basis of the kP method (KD) versus that of the kj method (K*) (Fig. 5B) , the K* estimates systematically deviated from the KD estimates when the K* estimates were low. This observation also pointed to the excessive subtraction of OMFD from the total radioactivity in the kj method when "true" Ve is significantly lower than unity, because the net clearance is roughly correlated with Ve' The values of the K�-KP ratio are unlikely to affe ct the estimates because OMFD accumulates gradually in plasma.
Without the constraint of a common Ve, the least squares optimization yielded an unexpected rela tionship between the free FDOPA in the striatum and the radioactivity in reference regions. On the basis of the kj analysis, the time course of the pre dicted sum of free FDOPA and OMFD in the brain approximated that of the total radioactivity in the reference region (Fig. 6 in Huang et al. , 1991) . With out the constraint of a common Ve, the kP analysis confirmed the finding. However, the free FDOPA in striatum with high L-DOPA decarboxylase activ ity must be significantly lower than that in a refer ence region with low L-DOPA decarboxylase activ ity. The model dictates that the distribution volume of the free FDOPA ( = M�(T)/C�(T» approaches KP/(k� + kP) in steady state. In contrast, with the constraint of a common Ve, the free FDOPA in the striatum was definitely lower than that in the frontal cortex (Fig. 6 in Kuwabara et al. , 1992a) .
The kP and kj analyses took the loss of FDA metabolites from the brain into account. The kj model assumed one transfer coefficient for the clearance of 1 8 F from the tissue. The kP model di vided FDA and its metabolites into nondiffusible and diffusible compartments to delay the escape of the diffusible metabolites relative to those of FDA and other nondiffusible metabolites. Therefore , the kP model required two additional coefficients; one for the transfer of free FDOPA to nondiffusible me tabolites (mainly FDA) and the other for the clear ance of the diffusible metabolites from brain. For the two models, a circulation time of 60 min was insufficient to determine the coefficients explicitly.
For this reason, we used popUlation means; k� = 0.02 min -1 and kr = 0.005 min -I for the kP anal ysis (Kuwabara et al. , 1992a) , and kt = 0.043 min-I for the kj analysis . For normal subjects, the magnitude of metabolite loss from the brain predicted by the two analyses ap peared comparable since the estimates of net clear ance of the two methods agreed (Fig. 5A ) and slightly exceeded those of the plasma slope intercept plot which had no provision for metabolite loss (Fig. 5B) .
Post-mortem studies of striatum of patients with Parkinson's disease (Bernheimer et al. , 1972) , as well as PET studies of living patients (Kuwabara et aI ., 1992b) , indicated pathological changes of dopa mine metabolism, including increased clearance of dopamine metabolites from the brain. Therefore , it is possible that the values of the loss coefficients (k� and k� of the k� method, and k: of the kj method) increase in patients. In a preliminary study (Kuwa bara et aI ., 1992b), we reported that k� and � in creased significantly in the putamen of patients with Parkinson's diseases. When the pathological changes of the metabolite clearance was fixed at a constant value for the analysis of 60-min circula tion, the � estimates increased by less than 10% compared with estimates based on a normal value of metabolite clearance (data not shown) . For this reason, we conclude that the use of a nonpatholog ical clearance for the striatum of patients with Par kinson's disease had no adverse effects on the pre sent observations .
The striatal uptake of FDOPA was decreased in Parkinson's disease, and the putamen was more se verely affected than the caudate nucleus , as shown also by others (Leenders et aI ., 1986b (Leenders et aI ., , 1990 Brooks et aI., 1990a,b) . The difference between normal vol unteers and Parkinson's disease was greater in the putamen than in the caudate nucleus. Thus , the putamen may be more sensitive to the severity of the disease than the caudate nucleus . Bernheimer et ai . (1973) and Kish et ai . (1988) noted the relative preservation of caudate dopamine levels in autopsy specimens from patients with Parkinson's disease. Therefore, the caudate nucleus and putamen must be considered separately in the evaluation of the severity of Parkinson's disease.
